Influence of menopause on high density lipoprotein-cholesterol and lipids

被引:40
作者
Kim, CJ [1 ]
Kim, TH [1 ]
Ryu, WS [1 ]
Ryoo, UH [1 ]
机构
[1] Chung Ang Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul 100272, South Korea
关键词
hormones; female; lipoproteins; lipids; menopause;
D O I
10.3346/jkms.2000.15.4.380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been generally accepted that high density lipoprotein cholesterol (HDL-C) level decreases with menopause in women. However, recent reports show different results. There is very little data concerning perimenopausal women. To verify these findings, lipids and lipoprotein(a) [Lp(a)] levels were compared among pre-, peri- and postmenopausal women of similar mean ages. Postmenopausal women had higher HDL-C levels than premenopausal women (p<0.001) and there was no difference between peri- and postmenopausal women. LDL-C level in perimenopausal women was lower than in postmenopausal women (p<0.001) and higher than in premenopausal women with borderline significance (p=.051). Total cholesterol levels showed stepwise elevation from premenopause to postmenopause. Perimenopausal women had lower Lp(a) levels than postmenopausal women (p<0.0005) and similar levels to premenopausal women. Lp(a) levels between 0.1 to 10.0 mg/dL were the most prevalent in pre- and perimenopausal women, and those between 10.1 to 20.0 mg/dL in postmenopausal women. In conclusion, menopause itself is associated with the elevation of HDL-C level, and the postmenopausal increase of coronary artery disease is not related to postmenopausal change of HDL-C level. Perimenopausal status, although transient, may favor Lp(a) and lipid profiles for delaying atherosclerosis.
引用
收藏
页码:380 / 386
页数:7
相关论文
共 33 条
[1]  
BERG K, 1974, CLIN GENET, V6, P230
[2]  
BERG K, 1989, LANCET, V2, P812
[3]   PLASMA-LIPID, LIPOPROTEIN CHOLESTEROL, AND APOPROTEIN DISTRIBUTIONS IN SELECTED UNITED-STATES COMMUNITIES - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
BROWN, SA ;
HUTCHINSON, R ;
MORRISETT, J ;
BOERWINKLE, E ;
DAVIS, CE ;
GOTTO, AM ;
PATSCH, W .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1139-1158
[4]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[5]   EFFECTS OF BILATERAL OOPHORECTOMY ON LIPOPROTEIN METABOLISM [J].
FARISH, E ;
FLETCHER, CD ;
HART, DM ;
SMITH, ML .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (01) :78-82
[6]   Perimenopausal changes in serum lipids and lipoproteins: A 7-year longitudinal study [J].
Fukami, K ;
Koike, K ;
Hirota, K ;
Yoshikawa, H ;
Miyake, A .
MATURITAS, 1995, 22 (03) :193-197
[7]   LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B AND LIPOPROTEIN-(A) ABNORMALITIES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, J ;
MCNAMARA, JR ;
ORDOVAS, JM ;
JENNER, JL ;
SILBERMAN, SR ;
ANDERSON, KM ;
WILSON, PWF ;
SALEM, DN ;
SCHAEFER, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :792-802
[8]   HOW DO WE EXPLAIN THE CLINICAL BENEFITS OF ESTROGEN - FROM BEDSIDE TO BENCH [J].
GERHARD, M ;
GANZ, P .
CIRCULATION, 1995, 92 (01) :5-8
[9]   LEVELS OF LIPOPROTEIN LP(A) DECLINE WITH NEOMYCIN AND NIACIN TREATMENT [J].
GURAKAR, A ;
HOEG, JM ;
KOSTNER, G ;
PAPADOPOULOS, NM ;
BREWER, HB .
ATHEROSCLEROSIS, 1985, 57 (2-3) :293-301
[10]   LIPOPROTEIN(A) IN CORONARY HEART-DISEASE - IS IT A RISK FACTOR AFTER ALL [J].
GUREWICH, V ;
MITTLEMAN, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :1025-1026